rs1012176
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001332.4(CTNND2):c.1628+25946C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 152,068 control chromosomes in the GnomAD database, including 4,391 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.24 ( 4391 hom., cov: 32)
Consequence
CTNND2
NM_001332.4 intron
NM_001332.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.391
Publications
5 publications found
Genes affected
CTNND2 (HGNC:2516): (catenin delta 2) This gene encodes an adhesive junction associated protein of the armadillo/beta-catenin superfamily and is implicated in brain and eye development and cancer formation. The protein encoded by this gene promotes the disruption of E-cadherin based adherens junction to favor cell spreading upon stimulation by hepatocyte growth factor. This gene is overexpressed in prostate adenocarcinomas and is associated with decreased expression of tumor suppressor E-cadherin in this tissue. This gene resides in a region of the short arm of chromosome 5 that is deleted in Cri du Chat syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
CTNND2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: Illumina
- neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: G2P
- benign adult familial myoclonic epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.237 AC: 36075AN: 151952Hom.: 4395 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36075
AN:
151952
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.237 AC: 36077AN: 152068Hom.: 4391 Cov.: 32 AF XY: 0.235 AC XY: 17435AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
36077
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
17435
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
9217
AN:
41476
American (AMR)
AF:
AC:
2563
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
652
AN:
3470
East Asian (EAS)
AF:
AC:
1937
AN:
5170
South Asian (SAS)
AF:
AC:
1159
AN:
4822
European-Finnish (FIN)
AF:
AC:
2492
AN:
10562
Middle Eastern (MID)
AF:
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17415
AN:
67978
Other (OTH)
AF:
AC:
475
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1418
2836
4255
5673
7091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
878
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.